Curated News
By: NewsRamp Editorial Staff
January 29, 2025
Sigyn Therapeutics, Inc. Appoints Michael Ryan to Board of Directors
Discuss on Reddit
LinkedIn
Substack
Telegram
GithubTLDR
- Sigyn Therapeutics appointed Michael Ryan, a seasoned executive and investor, to its Board of Directors, enhancing the company's strategic expertise.
- Sigyn Therapy aims to treat life-threatening infections through blood purification technologies, reducing viral pathogens, bacterial toxins, and pro-inflammatory cytokines from human blood plasma.
- Sigyn Therapeutics' innovative therapies offer strategic value to the dialysis and biopharmaceutical industry, potentially extending the lives of individuals with life-threatening conditions.
- Mr. Ryan's extensive industry experience and contributions to Sigyn Therapeutics introduce a compelling strategy to address global health challenges through advanced blood purification technologies.
Impact - Why it Matters
This news matters as it highlights the strategic move by Sigyn Therapeutics to enhance its leadership team with the appointment of Michael Ryan. Ryan's experience and expertise will play a crucial role in advancing the development of innovative blood purification technologies that have the potential to save lives and address critical global health challenges.
Summary
Sigyn Therapeutics, Inc. announces the appointment of Michael Ryan to its Board of Directors. Ryan, a seasoned executive and investor, brings a wealth of experience to the Company with his background in technology and life sciences. His expertise will aid Sigyn in developing life-saving blood purification technologies.
Source Statement
This curated news summary relied on this press release disributed by NewMediaWire. Read the source press release here, Sigyn Therapeutics, Inc. Appoints Michael Ryan to Board of Directors
